
For In Vitro Use Only — Not for Human Use
Synthetic GHRH analogue (Tesamorelin acetate), lyophilised powder (10mg, ≥98% purity) for laboratory research into receptor binding and endocrine signalling pathways.
Tesamorelin 10mg is a synthetic growth hormone-releasing hormone (GHRH) analogue supplied as a lyophilised powder for laboratory research use. It is selected within controlled environments for investigation into peptide structure, receptor interaction, and signalling pathways.
Within laboratory settings, Tesamorelin is studied for its interaction with growth hormone-releasing hormone (GHRH) receptors and associated endocrine signalling pathways. Research applications focus on receptor binding activity, peptide stability, and hormone pathway modelling under controlled experimental conditions.
Add 0.5ml of AA water until all powder is dissolved and then add 2.5ml of bac water, never shake.
Tesamorelin is a synthetic growth-hormone-releasing-hormone (GHRH) analogue investigated in vitro for its interaction with GHRH receptors and downstream endocrine signalling pathways.
Every 10mg vial is tested to ≥98% purity by RP-HPLC. A batch-specific Certificate of Analysis is available on request.
Tesamorelin requires an acetic-acid pre-solubilisation step before bacteriostatic water is added — swirl gently, never shake. See our peptide calculator for target concentrations and volumes.
Reconstituted Tesamorelin should be refrigerated at 2–8°C, protected from light, and used within the standard 28-day window for GHRH-family peptides.